AI Medical-Device Discoverability: Why a Hard-to-Search Regulatory Database Does Not Permit Exaggerated GEO

When clinicians search for an AI-enabled device, they need its authorisation status, indication, setting, and limits. Incomplete database metadata and hard-to-search PDFs can make discovery difficult, but they do not justify simplifying or exaggerating an authorisation claim.

Medical-device GEO starts with regulated facts that are traceable, current, and hard to misread.

FDA AI Search, published November 21, 2025, notes that more than 1,200 AI-enabled medical devices had received U.S. FDA marketing authorisation and explores semantic retrieval of authorisation summaries. The tool and its evaluation are not clinical advice, regulatory confirmation, or a finding that any device is safe or effective.

Maintain a minimum record of authorisation facts

On official pages, identify the product, authorisation or clearance reference, indication, intended users, setting, version, limitations, update date, and regulator source link. Separate marketing claims from the authorised scope. Never turn “searchable” into “suitable for every clinical scenario.”

Review AI answers as high-risk material

Use fixed clinical-information questions to check whether an answer confuses similar products, expands an indication, or omits human oversight or use limits. Route every error through regulatory, clinical, and legal processes rather than covering it with more marketing content.

GEO Radar at https://www.georadar.top can retain AI answers, sources, and timestamps so teams can identify descriptions requiring review. It does not validate device authorisation, clinical performance, or patient suitability.

Sources for this article

• arXiv, November 21, 2025, *FDA AI Search: Making FDA-Authorized AI Devices Searchable*: https://arxiv.org/abs/2602.00006 (authorised-device count, searchability challenges, semantic-retrieval tool, and research boundary)